Harrow, Inc. Files 8-K Report
Ticker: HROW · Form: 8-K · Filed: Sep 9, 2025 · CIK: 1360214
| Field | Detail |
|---|---|
| Company | Harrow, INC. (HROW) |
| Form Type | 8-K |
| Filed Date | Sep 9, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $250.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
Related Tickers: HROW
TL;DR
Harrow (HROW) filed an 8-K with financial exhibits. Keep an eye on disclosures.
AI Summary
On September 8, 2025, Harrow, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclosures related to the company's financial health and operations. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This filing indicates Harrow, Inc. is providing updated financial information or exhibits to the SEC, which could be relevant for investors assessing the company's current financial standing.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate adverse events.
Key Players & Entities
- HARROW, INC. (company) — Registrant
- 001-35814 (company) — SEC File Number
- 45-0567010 (company) — EIN
- September 8, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Harrow, Inc.?
The filing is a Current Report on Form 8-K, primarily reporting 'Other Events' and 'Financial Statements and Exhibits' as of September 8, 2025.
What is Harrow, Inc.'s exact name as specified in its charter?
Harrow, Inc. is the exact name of the registrant as specified in its charter.
In which state is Harrow, Inc. incorporated?
Harrow, Inc. is incorporated in Delaware.
What is Harrow, Inc.'s Central Index Key (CIK) number?
Harrow, Inc.'s Central Index Key (CIK) is 0001360214.
What is the SIC code for Harrow, Inc.?
The Standard Industrial Classification (SIC) code for Harrow, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 574 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-09-09 07:00:28
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share HROW The Nasdaq
- $250.0 million — nouncing the pricing of its offering of $250.0 million aggregate principal amount of the Compa
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- 0001493152-25-012840.txt ( ) — 290KB
- hrow-20250908.xsd (EX-101.SCH) — 4KB
- hrow-20250908_def.xml (EX-101.DEF) — 26KB
- hrow-20250908_lab.xml (EX-101.LAB) — 36KB
- hrow-20250908_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HARROW, INC. Dated: September 9, 2025 By: /s/ Andrew R. Boll Andrew R. Boll President and Chief Financial Officer